| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 251,626 | 225,861 | 247,186 | 315,815 | | Cost of Revenue | 196,183 | 181,032 | 195,087 | 241,055 | | | Gross Profit | 55,443 | 44,829 | 52,099 | 74,760 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 46,010 | 44,004 | 48,276 | 50,748 | | Non Recurring | 2,687 | (54) | 19,991 | 79,524 | | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 6,582 | 879 | (16,168) | (55,512) | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
| 265 |
-
| | Earnings Before Interest And Taxes | 1,751 | 879 | (15,903) | (55,512) | | Interest Expense | (2,484) | 2,484 | 3,089 | 4,108 | | Income Before Tax | 4,235 | (1,605) | (18,992) | (59,620) | | Income Tax Expense | 2,153 | (1,291) | (3,069) | (16,054) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 2,082 | (314) | (15,923) | (43,566) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 2,082 | (314) | (15,923) | (43,566) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $2,082 | ($314) | ($15,923) | ($43,566) |
|
0.11% Nasdaq 
0.08%
Income Statement
